HAVIT Blog
Science-backed guides on habits, sleep, nutrition, and movement.
All articles
Foundayo Side Effects: Nausea & Warnings (2026)
Foundayo's most common side effects are gastrointestinal — nausea, diarrhea, constipation, and vomiting — which are dose-dependent, tend to be worst around each dose increase, and usually settle as the body adapts. Rare but serious risks include a boxed warning for thyroid C-cell tumors plus pancreatitis and gallbladder disease, which need urgent medical care.
Gamify Weight Loss: Streaks & Habits That Stick on GLP-1
Gamifying weight loss means using streaks, habit-stacking, points, and small rewards to make GLP-1 tracking automatic instead of effortful. In trials, game elements added roughly 1,610 steps a day — and our most consistent trackers built the strongest habits.
Glapp Alternative for GLP-1 Users: An Honest 2026 Comparison — Havit vs Glapp
Looking for a Glapp alternative on Wegovy or Mounjaro? What Glapp does well, where it stops short on food and habits, and how HAVIT compares.
How to Keep a GLP-1 Diary: Shot, Weight & Habit Tracking
A useful GLP-1 diary needs only four things logged each time: shot day, weight, meals (protein), and side effects. With a record, the patterns behind your results and symptoms become visible, and the longer you keep it, the more it pays off. Aim for "one number plus one line," not a perfect journal.
GLP-1 Dose Tracker: Log Your mg & Titration Schedule
A GLP-1 dose tracker logs which milligram you took on which date and follows your titration — Wegovy 0.25→2.4, Zepbound 2.5→15. See how to track and share it.
GLP-1 for Perimenopause: Weight Gain & Insulin (2026)
GLP-1 for perimenopause is used to treat the weight gain, rising insulin resistance, and belly fat that begin during the transition years — often while you are still having periods — not perimenopause itself. Semaglutide (Ozempic, Wegovy) and tirzepatide (Mounjaro, Zepbound) can help, but protein and strength training are essential because perimenopause is when lean-muscle loss accelerates.
GLP-1 Period Changes, Fatigue & Hot Flashes (2026)
On a GLP-1 (semaglutide — Ozempic, Wegovy; or tirzepatide — Mounjaro, Zepbound), period changes and hot flashes are mostly indirect — driven by weight loss, hormone shifts, and midlife menopause overlap, not a direct drug action — while fatigue is a recognized side effect tied to eating less, dehydration, and low blood sugar. Track them; verify causes with your clinician.
